Delivery Order SPE2DB22D1202-SPE2DB24FVAG3
Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug Mounjaro in a 7.5 mg/0.5 ml pen, with a ceiling value of $13,867.71 and a performance period ending on June 4, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,035.75, is for the supply of the medication Mounjaro 5 mg/0.5 ml pen. It has a period of performance through September 17, 2024. The contract is not set aside for any socioeconomic program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,462.55 contract is for the supply of the drug Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) and has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Mounjaro 5 mg/0.5 ml pen. The award, valued at $3,156.00, is a firm fixed-price contract with an ultimate completion date of August 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,399.00, is for the delivery of the drug Mounjaro (5 mg/0.5 ml pen, 0.5 ml) and has a completion date of February 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,447.12, is a delivery order to supply the medication Mounjaro (5 mg/0.5 ml pen) for the DLA. The contract has a ceiling value of $5,447.12 and a period of performance through February 28, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $21,606.55 and has an ultimate completion date of January 17, 2025. It is for the procurement of the drug Mounjaro, a 12.5 mg/0.5 mL pen with a 0.5 mL volume. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This is a $6,283.30 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The order is for the drug Mounjaro, a 7.5 mg/0.5 ml pen, with a period of performance through April 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro 5 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $10,010.56 and a period of performance through July 10, 2025. This order is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication Mounjaro (12.5 mg/0.5 ml pen) in the amount of $3,983.55. The award date is August 19, 2024, and the ultimate completion date is August 20, 2024. This contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA...